サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1675469

皮膚科治療薬市場：皮膚疾患別、投与経路別、流通チャネル別、地域別、2025-2033年

Dermatological Drugs Market by Dermatological Diseases, Route of Administration, Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
皮膚科治療薬市場：皮膚疾患別、投与経路別、流通チャネル別、地域別、2025-2033年
出版日: 2025年03月01日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

皮膚科治療薬市場の世界市場規模は2024年に260億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに568億米ドルに達し、2025年から2033年にかけて8.64%の成長率（CAGR）を示すと予測しています。皮膚疾患の有病率の上昇、コスメシューティカルズに対する需要の増加、皮膚の健康に対する個人の意識の高まりが、市場を牽引する主な要因のひとつです。

皮膚科治療薬は、にきび、乾癬、湿疹、酒さ、皮膚がん、真菌感染症、皮膚、毛髪、爪に影響を及ぼすその他の疾患など、さまざまな皮膚疾患の治療に使用される医薬品です。これらの薬剤は、治療する皮膚疾患の種類に応じて、局所投与、経口投与、または注射によって使用されます。クリーム、軟膏、ジェル、スプレーなどの局所用皮膚科治療薬は、皮膚に直接塗布します。にきびや湿疹などの局所的な皮膚疾患の治療に最もよく使用されます。一方、全身性の皮膚科治療薬は経口または注射で服用するもので、皮膚疾患の根本的な原因をターゲットとして作用します。これらの薬剤は、乾癬のような重度または広範囲の皮膚疾患の治療に用いられることが多いです。これらの製品は化粧品と医薬品の両方の特性を持ち、皮膚の全体的な健康と見た目を改善するように設計されています。さらに、皮膚科治療薬は皮膚科医や皮膚の健康に精通した医療専門家によって処方されるため、世界中で需要が拡大しています。

皮膚科治療薬市場動向：

市場は主に、乾癬、湿疹、にきび、酒さ、皮膚がんなどの皮膚疾患の有病率の増加が牽引しています。さらに、このような病気にかかりやすい老年人口が増加していることも、成長を促す大きな要因となっています。これに加えて、皮膚の全体的な健康と外観を改善するために、医薬品的特性を持つ化粧品であるコスメシューティカルズを広く採用する個人も増えています。これは、健康な皮膚を維持することの重要性に対する個人の意識の高まりと相まって、市場の成長にプラスの影響を与えています。患者は現在、皮膚疾患の治療を求める意識が高まっており、皮膚科治療薬の全体的な需要増につながっています。さらに、経皮パッチ、ナノテクノロジー、マイクロニードルなどのドラッグデリバリーシステムにおける様々な技術進歩が、皮膚科治療薬市場の成長を促進しています。これらの新しいドラッグデリバリーシステムは薬剤の有効性を向上させ、患者のコンプライアンスを高める。さらに、消費者の可処分所得の増加、一般用医薬品（OTC）の人気の高まり、利用可能な治療オプションに関する認知度の向上なども、世界中で良好な市場見通しを生み出している要因のひとつです。

本レポートで扱う主な質問

  • 世界の皮膚科治療薬市場はこれまでどのように推移してきたか？
  • 世界の皮膚科治療薬市場における促進要因、抑制要因、機会は何か？
  • 各促進要因、抑制要因、機会が世界の皮膚科治療薬市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な皮膚科治療薬市場はどの国か？
  • 皮膚疾患別の市場内訳は？
  • 皮膚科治療薬市場で最も魅力的な皮膚疾患は？
  • 投与経路別の市場内訳は？
  • 皮膚科治療薬市場で最も魅力的な投与経路は？
  • 流通チャネル別の市場内訳は？
  • 皮膚科治療薬市場で最も魅力的な流通チャネルは？
  • 世界の皮膚科治療薬市場の競合構造は？
  • 世界の皮膚科治療薬市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の皮膚科治療薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：皮膚疾患別

  • にきび
  • 皮膚炎
  • 乾癬
  • 皮膚がん
  • その他

第7章 市場内訳：投与経路別

  • 経口
  • 非経口
  • 局所

第8章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • Bausch Health Companies Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GSK plc
    • LEO Pharma A/S（LEO Holding A/S）
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
図表

List of Figures

  • Figure 1: Global: Dermatological Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Dermatological Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Dermatological Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Dermatological Drugs Market: Breakup by Dermatological Diseases (in %), 2024
  • Figure 5: Global: Dermatological Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Dermatological Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Dermatological Drugs Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Dermatological Drugs (Acne) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Dermatological Drugs (Acne) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Dermatological Drugs (Dermatitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Dermatological Drugs (Dermatitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Dermatological Drugs (Psoriasis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Dermatological Drugs (Psoriasis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Dermatological Drugs (Skin Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Dermatological Drugs (Skin Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Dermatological Drugs (Other Dermatological Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Dermatological Drugs (Other Dermatological Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Dermatological Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Dermatological Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Dermatological Drugs (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Dermatological Drugs (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Dermatological Drugs (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Dermatological Drugs (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Dermatological Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Dermatological Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Dermatological Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Dermatological Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Dermatological Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Dermatological Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Dermatological Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Dermatological Drugs Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Dermatological Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Dermatological Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 80: Global: Dermatological Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Dermatological Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dermatological Drugs Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Dermatological Drugs Market Forecast: Breakup by Dermatological Diseases (in Million USD), 2025-2033
  • Table 3: Global: Dermatological Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Dermatological Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Dermatological Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Dermatological Drugs Market: Competitive Structure
  • Table 7: Global: Dermatological Drugs Market: Key Players
目次
Product Code: SR112025A7758

The global dermatological drugs market size reached USD 26.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 56.8 Billion by 2033, exhibiting a growth rate (CAGR) of 8.64% during 2025-2033. The rising prevalence of skin disorders, the increasing demand for cosmeceuticals, and the growing awareness among individuals about skin health represent some of the key factors driving the market.

Dermatological drugs are medications that are used to treat various skin conditions, including acne, psoriasis, eczema, rosacea, skin cancer, fungal infections, and other disorders affecting the skin, hair, and nails. These drugs can be applied topically, orally, or by injection, depending on the type of skin condition being treated. Topical dermatological drugs, including creams, ointments, gels, and sprays, are directly applied to the skin. They are most commonly used to treat localized skin conditions, such as acne or eczema. On the other hand, systemic dermatological drugs are taken orally or by injection and work by targeting the underlying cause of a skin condition. These drugs are often used to treat severe or widespread skin conditions, such as psoriasis. These products have both cosmetic and pharmaceutical properties, and they are designed to improve the overall health and appearance of the skin. Moreover, dermatological drugs are prescribed by dermatologists or other healthcare professionals with expertise in skin health, which is escalating their demand across the globe.

Dermatological Drugs Market Trends:

The market is primarily driven by the increasing prevalence of skin disorders such as psoriasis, eczema, acne, rosacea, and skin cancer. In addition, the rising geriatric population that is more susceptible to such ailments represents another major growth-inducing factor. Besides this, individuals are widely adopting cosmeceuticals, which are cosmetic products with pharmaceutical properties to improve the overall health and appearance of the skin. This, coupled with the growing awareness among individuals about the importance of maintaining healthy skin, is positively influencing the market growth. Patients are now more aware of seeking treatment for skin conditions, leading to an increase in the overall demand for dermatological drugs. Moreover, various technological advancements in drug delivery systems, such as transdermal patches, nanotechnology, and microneedles, are driving the growth of the dermatological drugs market. These new drug delivery systems improve the efficacy of drugs and enhance patient compliance. Furthermore, the rising disposable incomes of consumers, the growing popularity of over the counter (OTC) drugs and the increasing awareness regarding the available treatment options are some of the other factors creating a favorable market outlook across the globe.

Key Market Segmentation:

Dermatological Diseases Insights:

  • Dermatological Drugs Market
  • Acne
  • Dermatitis
  • Psoriasis
  • Skin Cancer
  • Others

Route of Administration Insights:

  • Oral
  • Parenteral
  • Topical

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Insights:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for dermatological drugs. Some of the factors driving the North America dermatological drugs market included the growing prevalence of skin conditions, the rising awareness regarding appearance, and the escalating demand for cosmeceuticals.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global dermatological drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Amgen Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GSK plc, LEO Pharma A/S (LEO Holding A/S), Novartis AG, Pfizer Inc., Sanofi S.A., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global dermatological drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global dermatological drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global dermatological drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive dermatological drugs market?
  • What is the breakup of the market based on dermatological diseases?
  • Which is the most attractive dermatological disease in the dermatological drugs market?
  • What is the breakup of the market based on the route of administration?
  • Which is the most attractive route of administration in the dermatological drugs market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the dermatological drugs market?
  • What is the competitive structure of the global dermatological drugs market?
  • Who are the key players/companies in the global dermatological drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dermatological Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Dermatological Diseases

  • 6.1 Acne
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Dermatitis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Psoriasis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Skin Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bausch Health Companies Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 LEO Pharma A/S (LEO Holding A/S)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.